Search Orphan Drug Designations and Approvals
-
Generic Name: | Interferon alfa-2a | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Roferon A | ||||||||||||||||
Date Designated: | 06/06/1989 | ||||||||||||||||
Orphan Designation: | Treatment of chronic myelogenous leukemia. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Hoffmann-La Roche, Inc. 340 Kingsland Street Nutley, New Jersey 07110 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Interferon alfa-2a |
---|---|---|
Trade Name: | Roferon A | |
Marketing Approval Date: | 10/19/1995 | |
Approved Labeled Indication: | Treatment of chronic myelogenous leukemia. | |
Exclusivity End Date: | 10/19/2002 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-